31 MCPyV and the immune system: Target and modulator. Issue 5 (May 2015)
- Record Type:
- Journal Article
- Title:
- 31 MCPyV and the immune system: Target and modulator. Issue 5 (May 2015)
- Main Title:
- 31 MCPyV and the immune system: Target and modulator
- Authors:
- Becker, J.C.
Hadrup, S.R.
Schrama, D.
Ritter, C. - Abstract:
- Abstract : Merkel cell carcinoma (MCC) is a aggressive skin cancer associated with the Merkel cell polyomavirus (MCPyV). Presence of tumor-infiltrating lymphocytes and immune competence are strongly correlated with the course of the disease. MCPyV encoded proteins should be highly effective targets for cytotoxic immune responses as they are both foreign to the host and specific for the infection. Srutinizing for T-cell responses against MCPyV proteins revealed responses against HLA-A1, -A2, -A3, -A11 and -B7 restricted epitopes derived from both Large and Small T antigen in MCC patients. Moreover, we demonstrate the processing and presentation of the oncoprotein derived peptides, as well as the functional activity of the T antigen-reactive T cells. Despite the expression of immunogenic viral proteins and the presence of reactive cytotoxic T cell, MCCs are able to evade the immune system. Infected transformed cells in general express activating NKG2D ligands such as MICA/B activating cellular immune responses. However, in none of the MCPyV positive MCC cell lines MICA/B were expressed on transcriptional or translational level. Immunohistochemistry of 54 MCC tumors further revealed that in the majority MICA was not detectable. Since MICA/B expression is frequently silenced by histone deacetylation the effect of the HDAC inhibitor SAHA was tested revealing an induction of MICA/B resulting in an boosted lysis by cytotoxic lymphocytes. Accordingly, ChIP analysis demonstratedAbstract : Merkel cell carcinoma (MCC) is a aggressive skin cancer associated with the Merkel cell polyomavirus (MCPyV). Presence of tumor-infiltrating lymphocytes and immune competence are strongly correlated with the course of the disease. MCPyV encoded proteins should be highly effective targets for cytotoxic immune responses as they are both foreign to the host and specific for the infection. Srutinizing for T-cell responses against MCPyV proteins revealed responses against HLA-A1, -A2, -A3, -A11 and -B7 restricted epitopes derived from both Large and Small T antigen in MCC patients. Moreover, we demonstrate the processing and presentation of the oncoprotein derived peptides, as well as the functional activity of the T antigen-reactive T cells. Despite the expression of immunogenic viral proteins and the presence of reactive cytotoxic T cell, MCCs are able to evade the immune system. Infected transformed cells in general express activating NKG2D ligands such as MICA/B activating cellular immune responses. However, in none of the MCPyV positive MCC cell lines MICA/B were expressed on transcriptional or translational level. Immunohistochemistry of 54 MCC tumors further revealed that in the majority MICA was not detectable. Since MICA/B expression is frequently silenced by histone deacetylation the effect of the HDAC inhibitor SAHA was tested revealing an induction of MICA/B resulting in an boosted lysis by cytotoxic lymphocytes. Accordingly, ChIP analysis demonstrated enhanced Histone H3 acetylation of the MICA/B promoters. Thus, MCPyV derived epitopes elicit cytotoxic T-cell responses which can be rendered functional effective by induction of NKG2D Ligand expression. … (more)
- Is Part Of:
- Oral oncology. Volume 51:Issue 5(2015:May)
- Journal:
- Oral oncology
- Issue:
- Volume 51:Issue 5(2015:May)
- Issue Display:
- Volume 51, Issue 5 (2015)
- Year:
- 2015
- Volume:
- 51
- Issue:
- 5
- Issue Sort Value:
- 2015-0051-0005-0000
- Page Start:
- e36
- Page End:
- e37
- Publication Date:
- 2015-05
- Subjects:
- Mouth -- Cancer -- Periodicals
Mouth -- Tumors -- Periodicals
Mouth Diseases -- Periodicals
Mouth Neoplasms -- Periodicals
Bouche -- Cancer -- Périodiques
Bouche -- Tumeurs -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9943105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/13688375 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/13688375 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.oraloncology.2015.02.032 ↗
- Languages:
- English
- ISSNs:
- 1368-8375
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6277.592000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25479.xml